Epics Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors (NCT07163325) | Epics Therapeutics | 2025-07-24 |
Track Epics Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.